Session Details

[27-11-am]Bacteriology, Mycology, Parasitology

Thu. Mar 27, 2025 8:30 AM - 10:06 AM JST
Thu. Mar 27, 2025 11:30 PM - 1:06 AM UTC
Room 11 (Fukuoka International Congress Center: 413 [4F])
Chair: Sanae Kurakado, Chikara Kaito

[27-11-am01S]Development of the novel α-1,3-glucan specific sandwich ELISA-like assay

○Kento Suzuki1, Daisuke Yamanaka1, Yoshiyuki Adachi1 (1. Tokyo Univ. Pharm. Life Sci.)

[27-11-am02S]Evaluation of susceptibility to various antimicrobial agents against Mycobacterium avium and analysis of resistance genes

○Futo Tsuchiuchi1, Shoji Seyama1, Ho Namkoong2, Kentaro Arikawa3, Tomotada Iwamoto3, Hirokazu Yano4, Yukiko Nishiuchi5, Fumito Maruyama5, Hiroshi Kida6, Naoki Hasegawa2, Hidemasa Nakaminami1 (1. Sch.Pharm,Tokyo Univ. Pharm. Life Sci., 2. Sch.Med,Keio Univ, 3. Kobe Institute of Health, Kobe City, 4. Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, 5. Hiroshima Univ, 6. Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center)

[27-11-am03S]Characteristics of hospital isolates of β-hemolytic streptococci

○Natsu Takada1, Takuma Yosida1, Shiori Takanezawa1, Ryouta Ninomiya1, Yuji Hirai2, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Dept. Infect. Dis., Tokyo Med. Univ. Hachioji Med. Cent.)

[27-11-am04S]Molecular epidemiological analysis of community-acquired MRSA prevalent in hospital

○Yuma Tomida1, Takuma Yoshida1, Takemi Ozeki1, Natsuki Oda1, Yuki Okura1, Tatsuya Numadate1, Megumi Sakaihori1, Yuji Hirai2, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Dept. Infect. Dis., Tokyo Med. Univ. Hachioji Med. Cent.)

[27-11-am05S]Molecular epidemiological and pathogenic characteristics of Staphylococcus lugdunensis isolated from patients with skin infections in Japan

○Mayuko Sawa1, Hiroshi Kaneko1, Ibuki Sugiyama1, Haruka Hiraoka1, Hana Kobayashi1, Yuka Yanagi1, Takumi Saito1, Miki Kanai1, Momoka Uchida1, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)

[27-11-am06]Establishment of a novel experimental system in Saccharomyces cerevisiae that enables co-expression of a large number of genes and re-engineering of the system

○Tetsuo Matsuzaki1,2, Geyao Dong2, Nakai Tsuyoshi3 (1. Hospital Pharmacy, Nagoya University Hospital, 2. Nagoya University Graduate School of Medicine , 3. Hospital Pharmacy, Fujita Health University Hospital)

[27-11-am07]Producing Completely Endotoxin-Free and Safe Pharmaceuticals Using Bacteria

○Go Kamoshida1, Daiki Yamaguchi2, Yuki Kaya2, Keita Oki1, Yoshiaki Sakairi1, Noriteru Yamada2, Yuuji Morita1 (1. Meiji Pharm. Univ., 2. Kyoto Pharm. Univ.)

[27-11-am08S]Evaluation of pathogenicity of non-encapsulated Streptococcus pneumoniae

○Yui Watanabe1, Juri Koizumi1, Mahiro Anju1, Keita Takahashi1, Takeaki Wajima2, Takuma Yoshida3, Shoji Seyama3, Hidemasa Nakaminami3 , Tetsuo Koshizuka1 (1. Gifu Pharmaceutical Univ. 2. Meijo Univ. Pharm. 3. Tokyo University of Pharmacy and Life science. Pharm)